Výsledky vyhledávání - "Kim Hung, Lo"

Akademický článek

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study

Autor: Atul Deodhar, Natalie J. Shiff, Cinty Gong, Eric K. H. Chan, Elizabeth C. Hsia, Kim Hung Lo, Alianu Akawung, Lilianne Kim, Stephen Xu, John D. Reveille

Publikováno v: Rheumatology and Therapy, Vol 10, Iss 4, Pp 983-999 (2023)

Abstract Introduction We studied the effect of intravenous (IV)-golimumab on fatigue and the association of fatigue improvement with clinical response post hoc in adults with active ankylosing spondylitis (AS) in the GO-ALIVE trial. Methods Patients

Externí odkaz: https://doaj.org/article/bf6b9377ad494054b35304fe6662ddaf

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

data to estimate clinical remission in pediatric inflammatory bowel disease

Autor: Nanhua Zhang, Chunyan Liu, Steven J Steiner, Richard B Colletti, Robert Baldassano, Shiran Chen, Stanley Cohen, Michael D Kappelman, Shehzad Saeed, Laurie S Conklin, Richard Strauss, Sheri Volger, Eileen King, Kim Hung Lo

Publikováno v: Journal of Comparative Effectiveness Research, Vol 12, Iss 4 (2023)

Aim: To evaluate the performance of the multiple imputation (MI) method for estimating clinical effectiveness in pediatric Crohn’s disease in the ImproveCareNow registry; to address the analytical challenge of missing data. Materials & methods: S

Externí odkaz: https://doaj.org/article/42b5218f58e84896b2411ed5c8d20447

Zobrazit plný text záznamu

Akademický článek

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study

Autor: Philip Mease, M. Elaine Husni, Soumya D. Chakravarty, Shelly Kafka, Dennis Parenti, Lilianne Kim, Kim Hung Lo, Elizabeth C. Hsia, Arthur Kavanaugh

Publikováno v: ACR Open Rheumatology, Vol 2, Iss 11, Pp 640-647 (2020)

Objective To evaluate whether intravenous (IV) golimumab produces improvements in skin and nail symptoms that are concomitant with improvements in quality of life (QoL) and joint symptoms in patients with psoriatic arthritis. Methods Patients were ra

Externí odkaz: https://doaj.org/article/16791a817ad3468185cd6445bb00e287

Zobrazit plný text záznamu

Akademický článek

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial

Autor: Philip Mease, M. Elaine Husni, Shelly Kafka, Soumya D. Chakravarty, Diane D. Harrison, Kim Hung Lo, Stephen Xu, Elizabeth C. Hsia, Arthur Kavanaugh

Publikováno v: Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-10 (2020)

Abstract Background In the GO-VIBRANT trial of intravenous golimumab in psoriatic arthritis (PsA), golimumab significantly inhibited radiographic progression. In post hoc analyses, we evaluated changes in total PsA-modified Sharp/van der Heijde score

Externí odkaz: https://doaj.org/article/945104ccbdc445aca228892252650489

Zobrazit plný text záznamu

Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus

Autor: Ronald F van Vollenhoven, Kenneth C Kalunian, Thomas Dörner, Bevra H Hahn, Yoshiya Tanaka, Robert M Gordon, Cathye Shu, Kaiyin Fei, Sheng Gao, Loqmane Seridi, Patrick Gallagher, Kim Hung Lo, Pamela Berry, Qing C Zuraw

Publikováno v: Annals of the rheumatic diseases, vol 81, iss 11
van Vollenhoven, R F, Kalunian, K C, Dörner, T, Hahn, B H, Tanaka, Y, Gordon, R M, Shu, C, Fei, K, Gao, S, Seridi, L, Gallagher, P, Lo, K H, Berry, P & Zuraw, Q C 2022, ' Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus ', Annals of the Rheumatic Diseases, vol. 81, no. 11, 222858, pp. 1556-1563 . https://doi.org/10.1136/ard-2022-222858
Annals of the Rheumatic Diseases, 81(11):222858, 1556-1563. BMJ Publishing Group
Annals of the rheumatic diseases, 81(11):222858, 1556-1563. BMJ Publishing Group

ObjectiveEvaluate the efficacy and safety of ustekinumab, an anti-interleukin-12/23 p40 antibody, in a phase 3, randomised, placebo-controlled study of patients with active systemic lupus erythematosus (SLE) despite receiving standard-of-care.Methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf60470861f84501272a90507fa11f9
https://doi.org/10.1136/ard-2022-222858

Zobrazit plný text záznamu

Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease

Publikováno v: Journal of Comparative Effectiveness Research.

Aim: To evaluate the performance of the multiple imputation (MI) method for estimating clinical effectiveness in pediatric Crohn's disease in the ImproveCareNow registry; to address the analytical challenge of missing data. Materials & methods: Simul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::facdff9117dd581fb29257d066323d83
https://doi.org/10.57264/cer-2022-0136

Zobrazit plný text záznamu

Validating the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease: A Novel Method for Assessing Disease Activity

Autor: Jeremy Adler, Richard B Colletti, Lenore Noonan, Tyler M Berzin, Adam S Cheifetz, Laurie S Conklin, Timothy C Hoops, Christopher S Huang, Blair Lewis, Daniel S Mishkin, Kim Hung Lo, Yongling Xiao, Sheri Volger

Publikováno v: Inflammatory Bowel Diseases.

Background To demonstrate treatment efficacy in Crohn’s disease (CD), regulatory authorities require that trials include an endoscopic remission/response end point; however, standardized endoscopic assessment of disease activity, such as the Simple

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a9a0b00b80b77e0df699754d6d81645
https://doi.org/10.1093/ibd/izac183

Zobrazit plný text záznamu

Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study

Autor: Atul A. Deodhar, Natalie J. Shiff, Cinty Gong, Elizabeth C. Hsia, Kim Hung Lo, Lilliane Kim, Stephen Xu, John D. Reveille

Publikováno v: Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 28(5)

This post hoc analysis assessed efficacy and safety of intravenous (IV) golimumab in ankylosing spondylitis (AS) patients with early disease (ED) versus late disease (LD).The phase 3, double-blind, GO-ALIVE study randomized patients to IV golimumab 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca6fd97c0e50efc2bc6c603f75a2c7f
https://pubmed.ncbi.nlm.nih.gov/35653615

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání